S
evere sepsis, characterized by systemic inflammation and acute organ dysfunction due to infection, is estimated to affect 1 million to 3 million patients in the United States each year and to be responsible for 250 000 to 350 000 in-hospital deaths. 1 Predicting the outcome for any individual patient with severe sepsis is difficult because the outcome depends on both the patient's health before infection and the degree of organ dysfunction after infection. Moreover, although a patient's health is related to his or her comorbid conditions, clearly not all patients with a common comorbid condition are in the same state of health before sepsis occurs.
We found previously that among patients with hematologic malignant tumors, an inpatient infection in the 90 days before a bloodstream infection was common and was associated with greater 30-day mortality after the bloodstream infection. 2 We hypothesized that patients who recently survived an infection before the occurrence of severe sepsis were in a poorer state of health than were patients with no history of infection before sepsis. Thus, we sought to improve the predictive accuracy of the Sequential Organ Failure Assessment (SOFA) score for patients with hematologic malignant tumors and severe sepsis by modifying the assessment to include points for having survived a recent infection.
Methods

Study Location and Patients
This study was conducted at the University of Chicago Medical Center, Chicago, Illinois, a 568-bed, university-affiliated, urban teaching hospital. Administrative billing records were used to identify all patients with hematologic malignant tumors (International Classification of Diseases, Ninth Revision codes 200-208) who were admitted to the adult medical intensive care unit (ICU) from September 1, 2009 , to September 1, 2014. Medical records were manually reviewed, and a patient's data were included if the patient had a diagnosis of severe sepsis or septic shock at the time of ICU admission according to the 1992 consensus definition. 3 Patients were excluded if their malignant tumor was in complete remission and they were no longer under the care of an oncologist. Only the first ICU admission for severe sepsis for each patient was included as an index case. The University of Chicago institutional review board approved this study and waived the need to obtain informed consent. The study was performed in accordance with the ethical standards set forth in the 1964 Declaration of Helsinki and its amendments.
Study Design and Data Collection.
We used a retrospective cohort design. Baseline demographic, malignant tumor, and ICU variables were collected by reviewing each patient's electronic medical record, which included nursing documentation, laboratory values, microbiology data, physicians' notes, radiology reports, and hospital discharge summaries. A patient was determined to have poor performance status if he or she could not perform activities of daily living at the time of hospital admission. The SOFA score includes 0 to 4 points for increasing severity of acute organ failure for each of 6 organ systems. 4 In this study, we calculated a SOFA score only on the first day of ICU admission. The primary outcome was death during the first 30 days after ICU admission.
For each patient, the most recent inpatient infection that occurred within 90 days before ICU admission was recorded. Infections were categorized as bacterial on the basis of the Centers for Disease Control and Prevention definition. 5 Infections were categorized as fungal if they met definite or probable criteria according to an international consensus definition. 6 Infections were classified as viral if clinical findings suggested a viral cause and results of culture, polymerase chain reaction assay, or histopathological findings indicated a virus. Inpatient infections treated at outside institutions were also included if documented in the medical records.
Score Derivation
The 50 patients admitted from September 1, 2009, to September 1, 2010, were evaluated to derive the modified SOFA (SOFA-HM) score. The variable "days since most recent infection" was initially treated as a continuous variable; this variable was assigned a value of 91 for patients who did not have an inpatient infection in the 90 days before ICU admission. To determine the nature of the relationship between days since most recent infection and 30-day mortality independent of the SOFA score, we adjusted the value of days since most recent infection by dividing it by the expected mortality on the basis of the SOFA score for each patient. We determined that a linear model approximated the relationship between risk for death and days since most recent infection because the addition of days since most recent infection squared term did not significantly alter the model (Figure 1) .
Because an inherent error exists in determining the exact day that an infection started, we created 3 point categories rather than 5. A total of 0 points was assigned for no infection within 90 days, 2 points for an infection 31 to 90 days before ICU admission, and 4 points for an infection 30 days or fewer before ICU admission. In univariate analysis, the odds ratios for death for each 2-point increase on the infection score were within the 95% CIs of the odds ratios for death for most of the other components of the SOFA score (Table 1) . Thus, the infection score was given the same weight as the other components of the SOFA score ( Table 2) . Table 3 gives the distributions of earlier infection points for patients in the derivation and validation cohorts.
Score Validation
For the subsequent 196 patients in the cohort admitted from September 1, 2010, to September 1, 2014, the predictive performance (calibration and discrimination) of the SOFA-HM score was compared with that of the SOFA score and the APACHE II score. 4, 7 Calibration is the degree to which actual outcomes match their predicted incidence. Calibration was assessed by using the Hosmer-Lemeshow goodness-of-fit test C statistic for observed and expected numbers of survivors and deaths across all of the strata of probabilities of death. A high P value (P > .05) indicates a good fit for the model. Calibration curves were also created by plotting predicted mortality rates stratified by 20% intervals of mortality risk (x-axis) against observed mortality rates (y-axis). Discrimination is the degree to which a score can be used to identify patients at highest risk for death. The discrimination was determined by calculating the area under the receiver operating characteristic curve and the 95% CI. 
95% CI Odds ratio Points
Abbreviations: SOFA-HM, Sequential Organ Failure Assessment-hematologic malignant tumor; NA, not applicable; -, reference. a For the components of the SOFA score, the patients with 1-2 points were grouped and patients with 3-4 points were grouped. b All patients died.
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Data Analysis
Continuous variables were reported as medians and interquartile ranges. The t test, Mann-Whitney test, 2 test, or Fisher exact test was used in bivariate testing, as appropriate, to determine if differences between groups were significant. Logistic regression analysis was used to identify risk factors present at the time of ICU admission that were independently associated with 30-day mortality after adjustments for age and SOFA-HM score. Initial models included all recorded variables; backward selection was then used to determine a final model. All tests were 2-sided, and a P of .05 or less was considered significant. All analyses were performed by using STATA 13.1 software (StataCorp).
Results
Between September 1, 2009, and September 1, 2014, a total of 433 distinct patients with hematologic malignant tumors were admitted to the medical ICU. A total of 27 patients (6.2%) were excluded from the study because their tumors were in complete remission and the patients were no longer being treated by an oncologist. A total of 246 patients (57%) met the criteria for severe sepsis.
Among the patients with severe sepsis, 98 (40%) had an inpatient infection in the 90 days before ICU admission for severe sepsis. Of these earlier infections, 11 (11%) occurred at outside hospitals. The most common organ systems involved were respiratory and primary bloodstream for both index cases and previous infections (Table 4) . When the derivation and validation cohorts were examined as a group, each 2-point increase in infection score was an independent risk factor for death. The magnitude of the effects was similar to the magnitudes of the respiratory, coagulation, and central nervous system components of the SOFA score ( Table 5 ). The liver, cardiovascular, and renal scores were not independently associated with 30-day mortality. Figure 2 shows the calibration curves for the SOFA-HM, SOFA, and APACHE II scores. HosmerLemeshow C statistic P values for the SOFA-HM, SOFA, and APACHE II scores were .42, .25, and .31, respectively, indicating that all scores fit the data well. Distribution of numbers of patients across all strata of expected mortality were more even for the SOFA-HM score than for the SOFA and APACHE II scores. The SOFA-HM score enabled discrimination of survivors from nonsurvivors significantly better than the SOFA score and the APACHE II score did (Figure 3 www.ajcconline.org (95% CI, 0.58-0.73) for the APACHE II score (P = .04 for difference with SOFA-HM).
In the validation cohort, 105 patients (54%) died during the first 30 days after ICU admission (Table 6 ). According to bivariate analysis, a relapsed /progressive hematologic malignant tumor (P = .008) and a greater number of days in the hospital before ICU admission (P = .02) were positively and significantly associated with mortality. Patients who died were more likely than were survivors to require invasive mechanical ventilation and vasoactive agents (P < .001). After adjustments for SOFA-HM score and age, the only variable significantly associated with 30-day mortality was increased days from hospital to ICU admission (Table 7) .
Discussion
In this study, we used a novel approach to improve the predictive accuracy of an ICU scoring system for patients with hematologic malignant tumors. In previous investigations, 8, 9 scoring systems have been modified by altering the weights of components or by combining aspects of different scoring systems. However, we hypothesized that a main limitation of these scoring systems is that they are missing variables for patients at high risk for death due to sepsis. 
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Abbreviations: SOFA-HM, Sequential Organ Failure Assessment-hematologic malignant tumor.; -, reference. a For the components of the SOFA score, the patients with 1-2 points were grouped and patients with 3-4 points were grouped.
As a whole, patients with hematologic malignant tumors are among patients with the highest risk for severe infections and for death due to the infections. 10 Our mortality rate of 54% is similar to the previously reported rate. [11] [12] [13] [14] However, all patients with hematologic malignant tumors do not have the same baseline risk for death due to severe sepsis. In our study, ICU mortality was inversely associated with time since most recent infection, independent of the degree of acute organ failure. As a result, we were able to derive a point system for the previous infection variable and incorporate the system into the SOFA score.
The SOFA-HM score was superior to the SOFA and APACHE II scores in 2 ways. First, the SOFA-HM score was significantly better than the SOFA and APACHE II scores for discriminating survivors from nonsurvivors. Second, the SOFA-HM scores had the most even distribution across all strata of expected mortality. ICU scoring systems may be used more often clinically if greater percentages of patients have either very high or very low expected mortality. The main limitation of the SOFA-HM score is that automating its determination could be challenging. Currently, a clinician must have access to and must review medical records for a patient in order to determine the score. After adjustments for age and SOFA-HM score, the only variable that remained significantly associated with mortality was time from hospital admission to ICU admission. Results of other studies 15, 16 of critically patients with hematologic malignant tumors also indicate that a greater number of days in the hospital before critical illness is associated with increased mortality. We also confirm the findings of previous investigators 11, 17, 18 that variables associated with malignant tumors (type of tumor, recent chemotherapy, neutrophil count) are not associated with mortality due to critical illnesses. The explanation for this surprising finding could be the fact that patients must be in a relatively good state of health to be eligible for chemotherapy. In addition, patients with neutropenia may have a more transient risk for severe infection than do patients who are immunosuppressed because of other reasons.
Because patients with severe sepsis have high prevalence of chronic diseases, they often require medical care in the months leading up to a hospitalization for severe sepsis. Prescott et al 19 estimated that in the year before an episode of severe sepsis, patients had mean of 1.44 hospitalizations and 24.2 days in the hospital per patient-year. Although the need for frequent health care most likely signifies a state of poor health, previous use of health care alone does not affect outcomes of sepsis independent of physiologically based scores. 20 Our findings suggest that in order to discover significant associations between previous use of health care and outcomes of sepsis, patients should be grouped according to comorbid conditions and the focus should be on infectious instead of noninfectious reasons for hospitalization.
Multiple reasons could explain why patients who survived recent infections could be at greater risk of death from future episodes of severe sepsis. A previous infection could be associated with other aspects of care that portend a poor prognosis. For instance, a history of recurrent infections may delay chemotherapy or alter goals of care for patients with aggressive malignant tumors. Also, patients with previous infections may be at higher risk for subsequent infections caused by virulent, antibiotic-resistant organisms than are patients with no history of infection. Finally, patients who survive an infection may enter an immune recovery phase; patients who experience severe sepsis during this recovery phase may have the highest risk for death. 21 Clearly, the main limitation of our study was the small number of patients in the sample. Although we derived the SOFA-HM score among a subgroup of 50 patients, we showed that the infection score influenced mortality to a similar extent as the other components of the SOFA score in the whole 246-patient cohort. Another limitation was that this study was conducted at a single health care center, a characteristic that potentially affects the generalizability of the findings. Clinicians in our ICU care for large numbers of critically ill patients with hematologic malignant tumors, and many of the patients have relapsed or progressive diseases. Thus, we suspect that the SOFA-HM might not be more accurate than the SOFA score in health care systems where most patients have newly diagnosed cancer and have less previous health care exposure.
Overall, our findings support the hypothesis that a patient's baseline health influences outcomes from severe sepsis independent of severity of acute illness. A major weakness of ICU scoring systems is that even though points are assigned for comorbid conditions, the scores do not adequately account for a patient's chronic health status. Among patients who are at high risk for severe sepsis, history of recent infection should be investigated as a surrogate for poor health. We suggest that clinicians who work at centers that care for many patients with hematologic malignant tumors investigate the predictive ability of the SOFA-HM score at their institutions. If the SOFA-HM is a better predictor of outcomes compared with other scoring systems, as it was in our study, it should be used to benchmark mortality rates over time and stratify patients who are enrolled in clinical trials.
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Abbreviation: SOFA-HM, Sequential Organ Failure Assessment-hematologic malignant tumor. a The interaction term between SOFA-HM and days from admission to the hospital to admission to the intensive care unit was nonsignificant (P = .58) and was not included in the model.
